1992
Book
Sharks Don't Get Cancer
How Shark Cartilage Could Save Your Life
Description
Overview and Purpose
Sharks Don't Get Cancer: How Shark Cartilage Could Save Your Life by Dr. I. William Lane and Linda Comaere (1992, updated 1993) explores the intriguing observation that sharks have an exceptionally low incidence of cancer and investigates the potential of shark cartilage as a natural agent to inhibit cancer growth and other angiogenesis-related diseases. The book aims to present scientific findings on shark biology, cartilage composition, and clinical research in a manner accessible to both medical professionals and lay readers. It emphasizes the promise of shark cartilage as a non-toxic, natural inhibitor of tumor angiogenesis, while also addressing the challenges faced in gaining acceptance within conventional medicine.
The authors provide a comprehensive review of the history, biology, laboratory studies, clinical trials, and broader health applications of shark cartilage, alongside discussions of regulatory, commercial, and conservation issues. The book serves as an informative resource for patients, caregivers, researchers, and advocates interested in alternative and complementary cancer therapies.
Introduction: Cancer Context and Shark Biology
The book opens by situating cancer as a leading cause of death worldwide, with increasing incidence and limited success from conventional treatments such as surgery, radiation, and chemotherapy. It highlights the urgent need for new preventive and therapeutic approaches.
Sharks, having survived over 400 million years with a remarkably low cancer rate (estimated at about 1 in 1 million), provide a biological puzzle that has inspired scientific inquiry. Their unique cartilage-based skeletons, which lack blood vessels and nerves, are hypothesized to contain substances that inhibit angiogenesis—the formation of new blood vessels essential for tumor growth and metastasis.
The authors introduce the angiogenesis theory pioneered by Dr. Judah Folkman and others, which posits that tumors cannot grow beyond a minimal size without developing their own blood supply. Shark cartilage, being avascular and rich in antiangiogenic proteins and mucopolysaccharides, is presented as a natural source of angiogenesis inhibitors.
Biology of Sharks and Cartilage
Chapter 1 details shark biology, emphasizing their ancient lineage and distinctive physiology. Sharks possess skeletons made entirely of cartilage rather than bone, which offers advantages such as lightness, flexibility, and buoyancy. Their cartilage differs chemically and structurally from mammalian cartilage, notably in its composition and calcification patterns.
Key shark features include:
- Highly developed sensory systems (hearing, smell, vision, and electroreception via Ampullae of Lorenzini) that aid in hunting.
- Continuous tooth replacement and powerful jaws.
- Robust immune systems producing unique antibodies that may contribute to their cancer resistance.
- Large livers rich in vitamin A, historically important as a nutritional source.
- Reproductive biology involving internal fertilization and live birth in many species.
The chapter also dispels common myths about sharks as man-eaters, noting that attacks on humans are rare and often accidental. It discusses traditional uses of shark products, especially cartilage, in various cultures, including Chinese medicine, where shark cartilage is consumed for health benefits.
Importantly, shark cartilage is free of heavy metals due to its avascular nature, making it safe for consumption. However, the authors acknowledge that while sharks rarely get cancer, it is not impossible.
Scientific Research and Angiogenesis Inhibition
The book traces the development of shark cartilage research beginning in the 1970s. Early work by Dr. John F. Burke and Ioannis V. Yannas used shark cartilage-derived collagen and glycosaminoglycans to create artificial human skin for burn victims, demonstrating the biological utility of cartilage components.
Subsequent laboratory studies revealed that cartilage contains inhibitors of angiogenesis, preventing blood vessel growth into tumors. Initial experiments with bovine cartilage showed anti-tumor effects but were limited by supply. Researchers turned to sharks, whose skeletons are entirely cartilage, providing abundant material.
Shark cartilage extracts were found to be approximately 1,000 times more potent than bovine cartilage in inhibiting angiogenesis on a weight basis. Clinical studies by Dr. John Prudden and others using bovine cartilage (Catrix) in cancer patients demonstrated tumor regression, immune stimulation, and no toxicity over long-term follow-up. Shark cartilage is believed to be even more effective.
Additional research confirmed that angiogenesis inhibition also prevents metastasis, a critical factor in cancer progression. The book highlights the work of Dr. Patricia D’Amore and studies correlating microvessel density with metastasis risk.
Shark cartilage contains multiple active components, including proteins and mucopolysaccharides such as chondroitin sulfate A, which collectively inhibit angiogenesis, modulate the immune system, and reduce inflammation. These combined effects likely produce synergistic therapeutic benefits.
Challenges and Regulatory Environment
Despite promising scientific evidence, shark cartilage therapy has faced significant resistance from the medical establishment and pharmaceutical industry. The authors attribute this to economic interests favoring patentable synthetic drugs, skepticism toward natural therapies, and regulatory hurdles.
The U.S. Food and Drug Administration (FDA) classifies shark cartilage as a food supplement rather than a drug, limiting medicinal claims and government research funding. The FDA’s role as a safety watchdog ensures truthful labeling but does not ban such supplements without court orders.
Processing methods are critical to preserve the heat- and solvent-sensitive antiangiogenic proteins in shark cartilage. The authors describe patented methods for drying and pulverizing cartilage into fine powders to maintain efficacy and absorption.
Early animal studies showed mixed results, with timing of administration (preloading before tumor implantation) emerging as a key factor. The National Cancer Institute initially expressed interest but later declined further research, citing a focus on cancer mechanisms rather than cures and concerns about conflicts of interest.
Clinical Trials and Therapeutic Applications
Clinical trials with shark cartilage have been conducted in several countries, often involving terminal cancer patients receiving high doses (up to 30-60 grams daily) orally and rectally. Notable studies include:
- Contreras Hospital, Mexico: Terminal cancer patients treated with shark cartilage showed tumor reduction (30-100%) and symptom improvement in most cases.
- Panama Project: Terminal patients experienced symptom relief, tumor shrinkage, and improved quality of life with dose adjustments up to 60 grams daily via enemas.
- Cuban Clinical Trial (1993): Among 27 terminal patients receiving 60 grams daily via retention enemas, 40% showed significant improvement, pain reduction, and tumor shrinkage without toxicity.
- New Jersey Physician Renato Martinez: Treated over 110 cancer patients with high doses (up to 120 grams daily), reporting dramatic tumor reductions and some tumor-free cases.
Rectal administration is preferred in advanced cancer due to compromised digestive function and better absorption through large blood vessels. Pain reduction is often the first noticeable effect, attributed to tumor shrinkage.
Shark cartilage therapy appears most effective against heavily vascularized solid tumors such as Kaposi’s sarcoma, breast, uterine, ovarian, brain, and bone metastases. However, some patients do not respond, and more rigorous, controlled studies are needed.
Other Health Benefits and Broader Applications
Beyond cancer, shark cartilage’s antiangiogenic and anti-inflammatory properties show promise for a range of angiogenesis-dependent diseases, including:
- Arthritis (Rheumatoid and Osteoarthritis): Studies report significant pain reduction, improved joint function, and slowed cartilage degeneration without toxicity. Shark cartilage offers a safer alternative to NSAIDs, which carry risks such as gastrointestinal bleeding.
- Psoriasis and Skin Conditions: Cartilage preparations have induced remission or improvement in many patients, reducing scaling, redness, and itching.
- Enteritis and Intestinal Inflammation: Oral shark cartilage has alleviated symptoms and improved patient strength.
- Eye Diseases: Conditions like diabetic retinopathy, macular degeneration, and neovascular glaucoma, caused by pathological angiogenesis, may benefit from shark cartilage, though formal studies are pending.
Contraindications include individuals requiring new blood vessel growth, such as recent heart attack patients, pregnant women, recent surgery patients, and children without medical supervision.
Conservation and Ethical Considerations
The book raises concerns about shark population depletion due to overfishing and finning, often with wasteful discarding of meat and cartilage. It advocates for sustainable harvesting and better utilization of shark cartilage to support medical uses and conserve shark species.
Conclusion and Future Directions
The authors emphasize the need for increased public awareness, consumer unity, and further scientific research to realize the full therapeutic potential of shark cartilage. They highlight the challenges posed by regulatory frameworks, commercial interests, and skepticism within conventional medicine.
Early clinical results showing dramatic responses in advanced cancer patients are encouraging, but the market is flooded with untested, adulterated shark cartilage products, often misleading consumers. The authors stress the importance of quality control, proper processing, and accurate dosing to preserve efficacy.
They advocate for patient advocacy similar to AIDS activists’ efforts to expedite drug approvals and access. The book includes a glossary of medical and biological terms, a comprehensive bibliography citing key researchers and studies, and an index covering a wide range of related topics.
Author Backgrounds
Dr. I. William Lane holds a Ph.D. in Agricultural Biochemistry and Nutrition, with experience working alongside Nobel laureates and a background in marine resource management. He has focused extensively on shark cartilage research for cancer and related diseases.
Linda Comaere holds degrees in English and is a freelance writer with a personal interest in cancer due to family losses. Her husband is a cancer research biochemist, contributing to the book’s scientific grounding.
Strengths and Limitations
Strengths:
- Comprehensive synthesis of shark biology, cartilage chemistry, and cancer research.
- Presentation of both laboratory and clinical evidence supporting shark cartilage’s antiangiogenic properties.
- Discussion of broader therapeutic applications beyond cancer.
- Insight into regulatory, commercial, and conservation challenges.
- Accessible language bridging scientific and lay audiences.
Limitations and Cautions:
- Clinical trials described are often small, preliminary, or uncontrolled; rigorous, large-scale studies remain lacking.
- The book does not endorse shark cartilage as a standalone cancer cure but presents it as a promising adjunct or alternative therapy under investigation.
- Readers are cautioned to consult qualified health professionals before using shark cartilage or other treatments.
- Potential variability in product quality and dosing complicates consumer use.
- Conservation concerns highlight ethical considerations in sourcing shark cartilage.
Utility for Cancer-Options Reference
This book provides a detailed, scientifically grounded overview of shark cartilage as a natural antiangiogenic agent with potential applications in cancer treatment and prevention, as well as other angiogenesis-related diseases. It contextualizes the therapy within the broader landscape of cancer research, regulatory challenges, and alternative medicine.
For patients and caregivers exploring complementary options, the book offers valuable insights into the rationale, evidence, and practical considerations of shark cartilage therapy. For researchers and clinicians, it summarizes decades of research and highlights areas needing further study.
Its balanced presentation, including both promise and limitations, makes it a useful resource for informed decision-making and advocacy in integrative oncology.





